Systematic review / meta-analysis / 2015
In a meta-analysis, berberine showed therapeutic effects on type 2 diabetes, hyperlipidemia, and hypertension, with no serious adverse reactions reported.
A meta-analysis analyzed 27 randomized controlled clinical trials involving 2,569 patients. For type 2 diabetes, berberine with lifestyle intervention or oral hypoglycemics tended to lower FPG, PPG, and HbA1c more than lifestyle intervention alone, placebo, or hypoglycemics alone, though berberine alone did not significantly differ from oral hypoglycemics. For hyperlipidemia, berberine combined with lifestyle intervention or lipid-lowering drugs was better at reducing TC and LDL-C and raising HDL-C. For hypertension, berberine with lifestyle intervention or hypotensors lowered blood pressure more than controls. No serious adverse reactions were reported, but the authors concluded that due to limited overall study quality, the therapeutic benefit could be substantiated to a limited degree.
- Study type
- Systematic review and meta-analysis of randomized controlled trials
- Who was studied
- 2,569 patients across 27 randomized controlled clinical trials
- What was measured
- FPG, PPG, HbA1c, TC, LDL-C, HDL-C, TG, blood pressure, and adverse reactions
THE PAPER
Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension.
Lan J, Zhao Y, Dong F, Yan Z, Zheng W, Fan J, Sun G. J Ethnopharmacol, 2015.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.